About Bio Essence
Bio Essence Corp. (OTCQB: BIOE) is a publicly traded healthcare company headquartered in Irvine, California. Incorporated in 2000, the Company has more than 26 years of operating experience in the natural-health industry. That experience provides the foundation for its transition toward an AI-enabled healthcare infrastructure platform.
Our Strategic Direction
BIOE aims to connect practitioners, patients, laboratories, pharmacies, wellness providers and health brands through a common technology layer. Our strategic focus includes practitioner AI agents, patient AI agents, structured knowledge, workflow technology and marketplace connectivity.
Why BIOE
- Healthcare Operating Experience: Longstanding experience serving the natural-health and practitioner market informs our platform strategy.
- Practitioner Relationships: Industry relationships provide insight into professional workflows and unmet digital needs.
- Public Company Platform: BIOE is an SEC-reporting company subject to applicable periodic disclosure, governance and financial reporting requirements.
- Technology Foundation: Our development focus includes AI agents, structured knowledge, workflow support and ecosystem connectivity.
An Existing Healthcare Base Supporting a Digital Strategy
50K+
Private Clinics
100K+
Practitioners
200K+
Active Clients
1M+
Clients Served Historically
These are Company-reported measures relating to BIOE's broader natural-health business. They are not software subscriber counts or platform revenue. Management believes the existing network may provide an early-adoption base for digital services; conversion to paying digital users is not guaranteed.
Building Healthcare Intelligence Infrastructure
BIOE's long-term strategy is to evolve from a healthcare operating company into a healthcare intelligence infrastructure platform. The roadmap combines practitioner tools, network connectivity, structured knowledge and patient engagement.
Four Phase Growth Roadmap
Phase I — Practitioner AI Infrastructure
Develop personalized AI and workflow tools for practitioners.
Phase II — Healthcare Network
Connect practitioners with laboratories, pharmacies, wellness providers and health brands.
Phase III — Healthcare Intelligence Infrastructure
Expand BIOE OS™, Wisdom Engine™ and structured knowledge capabilities toward enterprise use.
Phase IV — Patient AI Agent Infrastructure
Develop personalized health education, navigation, engagement, wellness guidance and continuity tools.
Roadmap note: The phases describe strategic development priorities, rather than completed milestones or committed launch dates. Timing and scope may change.
A Multi Layer Recurring Revenue Strategy
BIOE's planned business model is designed to increase recurring, scalable software and platform revenue over time. Proposed revenue streams include:
- Practitioner AI subscriptions
- Patient AI subscriptions
- Platform and SaaS subscriptions
- Enterprise licensing
- Marketplace technology fees
- Workflow and API services
- Supporting healthcare services
Revenue note: These are planned revenue opportunities. They should not be interpreted as current platform revenue, established pricing or financial forecasts.
Our Long Term Vision
We envision a connected ecosystem where practitioners can access personalized AI assistants, patients can receive useful education and navigation support, and healthcare organizations can connect through intelligent digital infrastructure. Our ambition is to make integrative healthcare more connected while supporting the practitioner-patient relationship.
One Platform. Two AI Agents. One Connected Ecosystem.
Our strategy brings practitioner and patient AI agents together through a common intelligence and connectivity layer. BIOE OS™, Wisdom Engine™ and Knowledge Graph™ are intended to support structured knowledge, connected workflows and ecosystem participation.
- Practitioner AI Agent: Planned tools for knowledge organization, workflow support and professional decision support.
- Patient AI Agent: Planned tools for health education, care navigation, engagement and continuity.
- Connected Healthcare Ecosystem: Connecting laboratories and diagnostics, pharmacies and wellness providers, health brands and enterprise partners through platform technology.
A Connected Intelligence Layer for Integrative Healthcare
BIOE is developing a platform intended to organize healthcare knowledge, support professional workflows and connect participants across the integrative healthcare ecosystem. Technology is intended to strengthen the practitioner-patient relationship.
Practitioner AI Agent. Planned practitioner tools are intended to help organize professional knowledge, retrieve relevant information and support everyday workflows. Practitioner-specific AI environments are designed to support professional decision-making while keeping the practitioner responsible for clinical judgment.
Patient AI Agent. Planned patient-facing AI tools are intended to support health education, care navigation, engagement and continuity. Our goal is to help patients stay connected with practitioners and appropriate healthcare resources.
- BIOE OS™: The planned operating layer for connected AI agents, workflows and ecosystem services.
- Wisdom Engine™: The planned intelligence layer supporting knowledge retrieval and AI-enabled workflows.
- Knowledge Graph™: Structured knowledge capabilities intended to organize information and relationships across the platform.
Technology Development Focus
- Practitioner-specific AI and workflow support
- Patient-facing AI for education, navigation, engagement and continuity
- Structured knowledge and retrieval capabilities
- Secure knowledge environments and access controls
- Administrative, monitoring and audit capabilities
- Flexible AI model orchestration and scalable platform infrastructure
Platform capabilities are under development. These descriptions reflect BIOE's planned development direction. Final features, product availability, adoption and commercial terms are not guaranteed.
Investor Relations
Bio Essence Corp. (OTCQB: BIOE) is pursuing a long-term transition toward AI-enabled healthcare infrastructure. Investors can review our SEC filings for information about our strategy, financial condition and risks.
Review Bio Essence Corp.'s annual, quarterly and current reports through the SEC's EDGAR database.
SEC Filings
2026 Current Report Amendment 8K/A
2026 Quarterly Report 10Q-Q1
2026 Current Report 8K
2025 Annual Report 10K
2025 Quarterly Report 10Q-Q3
2025 Quarterly Report 10Q-Q2
2025 Quarterly Report 10Q-Q1
2024 Annual Report 10K
2024 Quarterly Report Amendment 10Q-Q2
2024 Quarterly Report Amendment 10Q-Q1
2024 Quarterly Report 10Q-Q3
2024 Quarterly Report Amendment 10Q-Q2
2024 Quarterly Report Amendment 10Q-Q1
2024 Report of proposed sale of securities Amendment 144
2024 Report of proposed sale of securities 144
2024 Quarterly Report Amendment 10Q-Q1
2024 Current Report 8K
2024 Quarterly Report Amendment 10Q-Q2
2024 Quarterly Report 10Q-Q2
2024 Current Report 8K
2024 Current Report 8K
2024 Current Report 8K
2024 Report of proposed sale of securities 144
2024 Quarterly Report 10Q-Q1
2023 Annual Report 10K
2024 Current Report 8K
2023 Current Report 8K
2023 Quarterly Report 10Q-Q3
2023 Current Report 8K
2023 Quarterly Report 10Q-Q2
2023 Current Report 8K
2023 Quarterly Report 10Q-Q1
2022 Annual Report 10K
2022 Quarterly Report 10Q-Q3
2022 Quarterly Report 10Q-Q2
2022 Quarterly Report 10Q-Q1
2021 Annual Report 10K
2021 Quarterly Report 10Q-Q3
2021 Quarterly Report 10Q-Q2
2021 Quarterly Report 10Q-Q1
2020 Annual Report 10K
2020 Current Report 8K
Leadership Team and Board of Directors
Yin Yan, JD, MBA
Chairman & Chief Executive Officer
Licensed to practice law in New South Wales, Australia. Juris Doctor from the University of New South Wales; Bachelor of Science in Computer Information Systems from Arizona State University.
William Sluss
Chief Financial Officer & Director
Lawyer and Certified Public Accountant. Juris Doctor from Irvine University College of Law; Bachelor's degree in Accounting from the University of Virginia.
Dr. Siyavash Fooladian, MD, MPH
Director
Licensed physician. Doctor of Medicine and Master of Public Health from the George Washington University School of Medicine; Bachelor's degree in History and Education from UCLA.
Tuan Tran
Vice President of Operations
Forward-Looking Statements
This website contains forward-looking statements regarding Bio Essence Corp.'s business transformation, technology platform development, commercialization roadmap, business model and long-term strategic vision. Actual results may differ materially. Planned capabilities, adoption, revenue and market position are not guaranteed. Investors should review the Company's SEC filings for financial information, risk factors and other important disclosures.
Contact Bio Essence
Connect with Bio Essence to learn more about our company, platform strategy and potential ecosystem collaborations.
Company: Bio Essence Corp.
Trading Symbol: OTCQB: BIOE
Address: 2955 Main Street, Suite 202, Irvine, CA 92614
Email: [email protected]
Website: bioecsencecorp.com